Cargando…
Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation
Metabolomic studies of increased fat oxidation showed increase in circulating acylcarnitines C2, C8, C10, and C12 and decrease in C3, C4, and C5. We hypothesize that urinary F2-isoprostanes reflect intensity of fatty acid oxidation and are associated with circulating C2, C8, C10, and C12 directly an...
Autores principales: | Il'yasova, Dora, Wagenknecht, Lynne E., Spasojevic, Ivan, Watkins, Steven, Bowden, Donald, Wang, Frances, D'Agostino, Ralph B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352765/ https://www.ncbi.nlm.nih.gov/pubmed/25802683 http://dx.doi.org/10.1155/2015/729191 |
Ejemplares similares
-
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI
por: Il’yasova, Dora, et al.
Publicado: (2012) -
Urinary F(2)-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes
por: Il'yasova, Dora, et al.
Publicado: (2012) -
A Pilot Study of Associations Between Visceral Fat, IL-6, and Urinary F(2)-Isoprostanes in Older Adults Exposed to a Diet Intervention
por: Hoover, Sarah E, et al.
Publicado: (2021) -
Effects of 2 years of caloric restriction on oxidative status assessed by urinary F2‐isoprostanes: The CALERIE 2 randomized clinical trial
por: Il'yasova, Dora, et al.
Publicado: (2018) -
African Ancestry Gradient Is Associated with Lower Systemic F(2)-Isoprostane Levels
por: Annor, Francis, et al.
Publicado: (2017)